Literature DB >> 15215476

Small airways in COPD.

Peter J Barnes1.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15215476     DOI： 10.1056/NEJMp048102

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  35 in total

1.  Relevance of lower airway bacterial colonization, airway inflammation, and pulmonary function in the stable stage of chronic obstructive pulmonary disease.

Authors:  M Zhang; Q Li; X-Y Zhang; X Ding; D Zhu; X Zhou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-20       Impact factor: 3.267

Review 2.  Innate immune responses and chronic obstructive pulmonary disease: "Terminator" or "Terminator 2"?

Authors:  Robert P Schleimer
Journal:  Proc Am Thorac Soc       Date:  2005

Review 3.  Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted.

Authors:  Kendra J Greenlee; Zena Werb; Farrah Kheradmand
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

4.  Impact of the loss of Hoxa5 function on lung alveogenesis.

Authors:  Isabel Mandeville; Josée Aubin; Michelle LeBlanc; Mélanie Lalancette-Hébert; Marie-France Janelle; Guy M Tremblay; Lucie Jeannotte
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

5.  Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease.

Authors:  Sanjay Sethi; Jane Maloney; Lori Grove; Catherine Wrona; Charles S Berenson
Journal:  Am J Respir Crit Care Med       Date:  2006-02-10       Impact factor: 21.405

6.  Chronic obstructive pulmonary disease: an overview.

Authors:  John F Devine
Journal:  Am Health Drug Benefits       Date:  2008-09

Review 7.  Airway epithelial stem cells and the pathophysiology of chronic obstructive pulmonary disease.

Authors:  Scott H Randell
Journal:  Proc Am Thorac Soc       Date:  2006-11

Review 8.  Systems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease.

Authors:  Joanna L Richens; Richard A Urbanowicz; Elizabeth A M Lunt; Rebecca Metcalf; Jonathan Corne; Lucy Fairclough; Paul O'Shea
Journal:  Respir Res       Date:  2009-04-22

Review 9.  Long-acting beta2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety.

Authors:  Andrea Rossi; Sonia Khirani; Mario Cazzola
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

10.  Altered effector function of peripheral cytotoxic cells in COPD.

Authors:  Richard A Urbanowicz; Jonathan R Lamb; Ian Todd; Jonathan M Corne; Lucy C Fairclough
Journal:  Respir Res       Date:  2009-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.